OneSource Specialty Pharma Limited (NSE:ONESOURCE)

NSE:ONESOURCE Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023
Period Ending	Dec 31, 2024	Mar 31, 2024	Mar 31, 2023
Revenue	10,920	1,719	387.14
Revenue Growth (YoY)	-	344.07%	-
Cost of Revenue	3,576	852.13	336.43
Gross Profit	7,345	867.06	50.71
Selling, General & Admin	1,878	825.5	749.29
Other Operating Expenses	2,561	844.61	808.7
Operating Expenses	6,688	2,433	2,215
Operating Income	656.96	-1,566	-2,164
Interest Expense	-1,493	-853.99	-401.06
Interest & Investment Income	17.65	17.65	14.67
Currency Exchange Gain (Loss)	-5.75	-5.75	-91.59
Other Non Operating Income (Expenses)	76.12	-38.97	-73.21
EBT Excluding Unusual Items	-748.21	-2,447	-2,715
Gain (Loss) on Sale of Investments	7.57	7.57	1.15
Gain (Loss) on Sale of Assets	-58.08	-58.08	-
Asset Writedown	-1,159	-1,159	-1,451
Pretax Income	-1,907	-3,657	-4,156
Earnings From Continuing Operations	-1,566	-3,657	-4,156
Earnings From Discontinued Operations	-	-254.68	-3,842
Net Income	-1,566	-3,912	-7,998
Net Income to Common	-1,566	-3,912	-7,998
Shares Outstanding (Basic)	92	42	40
Shares Outstanding (Diluted)	92	42	40
Shares Change (YoY)	-	4.34%	-
EPS (Basic)	-16.99	-94.15	-200.87
EPS (Diluted)	-16.99	-94.15	-200.87
Free Cash Flow	-	-1,710	-2,068
Free Cash Flow Per Share	-	-41.15	-51.93
Gross Margin	67.26%	50.43%	13.10%
Operating Margin	6.02%	-91.09%	-558.99%
Profit Margin	-14.34%	-227.53%	-2066.00%
Free Cash Flow Margin	-	-99.45%	-534.07%
EBITDA	1,500	-803.03	-1,507
EBITDA Margin	13.73%	-46.71%	-
D&A For EBITDA	842.56	762.95	656.8
EBIT	656.96	-1,566	-2,164
EBIT Margin	6.02%	-91.09%	-
Revenue as Reported	11,078	1,761	414.06
Advertising Expenses	-	5.04	10.44

Source: S&P Global Market Intelligence. Standard template. Financial Sources.